JAKAFI (Ruxolitinib) Emerging Drug Insights and Market Forecasts, 2019-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
24 janv. 2024 07h57 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "JAKAFI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
NanoFlu Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032: A Nanoparticle Influenza Vaccine Produced in Novavax' SF9 Insect Cell Baculovirus System
24 janv. 2024 07h56 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "NanoFlu Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
Type 1 Diabetes Mellitus Treatment Innovation: Diamyd Emerging Drug Insight and Market Forecast up to 2032 - Prospects in Transforming Type 1 Diabetes Management
24 janv. 2024 07h55 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Diamyd Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Groundbreaking Report Uncovers...
Glioblastoma Multiforme Treatment Innovations: MDNA55 Drug Insight and Market Forecast to 2032
24 janv. 2024 07h54 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "MDNA55 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The landscape of glioblastoma...
ReNu (Replace with NuTech Medical) Emerging Drug Insight and Market Forecasts, 2032: A Cryopreserved, Amniotic Suspension Allograft (ASA) to Manage Symptomatic Knee OA
24 janv. 2024 07h53 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ReNu Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
LANTIDRA (Donislecel) Emerging Drug Insights and Market Forecasts, 2019-2032: A Novel Cellular Therapy Being Evaluated for Use in Brittle Type 1 Diabetes
24 janv. 2024 07h51 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "LANTIDRA Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "LANTIDRA Emerging Drug...
GLIOVAC (ERC1671) Emerging Drug Insight and Market Forecasts, 2032: Comprehensive Analysis of the Future of Glioblastoma Multiforme Treatment in Major Markets
24 janv. 2024 07h50 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "GLIOVAC Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The report meticulously...
Myotonic Dystrophy Market Forecast: Comprehensive Study on NAMUSCLA (Mexiletine) - Forecasts to 2032
24 janv. 2024 07h49 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "NAMUSCLA Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The latest research...
Berubicin Emerging Drug Insights and Market Forecasts, 2019-2032: An Anthracycline, A Class of Anticancer Agents that are Among the Most Powerful Chemotherapy Drugs
24 janv. 2024 07h48 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Berubicin Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
Healthcare Industry Report: DB102 Emerging Drug Insights and Market Forecast for DLBCL through 2032
24 janv. 2024 07h47 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DB102 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. A newly compiled research report...